Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cytokinetics Inc (CYTK) vs Direxion Daily Semiconductor Bull 3X Shares (SOXL) Price & Performance

Cytokinetics IncTrade
Direxion Daily Semiconductor Bull 3X SharesTrade

Price performance (Past 24H)

Key statistics

Cytokinetics Inc vs Direxion Daily Semiconductor Bull 3X Shares — how do they compare? Cytokinetics Inc trades at $76.67 (market cap $10.63B), while Direxion Daily Semiconductor Bull 3X Shares trades at $142.08. The key difference: Cytokinetics Inc is trading nearer its 52-week high, Direxion Daily Semiconductor Bull 3X Shares nearer its low. Which is the better fit depends on your goals.

CYTKSOXL
Market Cap
$10.63B
Sector
TechnologyLeveraged / Inverse
52-Week High
$87.26$300.77
52-Week Low
$34.31$24.91
Enterprise Value
$10.74B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cytokinetics Inc

CYTK trades at $76.24, down 1.61% over 24 hours, with a bearish technical signal from moving averages and neutral oscillators. The company reported a Q2 2026 loss of $1.50 per share, beating estimates, while revenue reached $88.04 million in 2025. Despite negative profitability margins, strong analyst sentiment exists with 34 buy ratings and a consensus price target of $111.14, driven by optimism around Myqorzo's commercial uptake and recent UK regulatory approval.

The outlook hinges on Myqorzo's commercial execution and pipeline expansion, offering significant upside if revenue growth accelerates. Key risks include persistent cash burn, high debt-to-asset ratio of 81.23%, and competitive pressures in the cardiovascular drug market. Investors should weigh the high valuation (P/S of 140.65) against the potential for future profitability breakthroughs.

Direxion Daily Semiconductor Bull 3X Shares

SOXL, the Direxion Daily Semiconductor Bull 3X Shares ETF, surged 13.02% to $146.92 amid renewed semiconductor sector optimism. The leveraged ETF remains in a technical bearish trend despite the recent rally, with moving averages signaling continued downward pressure. Recent news highlights significant government semiconductor funding and AI-driven demand catalysts, though the fund has experienced extreme volatility, dropping over 60% from its peak earlier this year before this rebound.

The outlook remains volatile with leveraged exposure amplifying both gains and losses. Investment opportunity exists for aggressive investors betting on sustained semiconductor recovery and AI infrastructure spending, but risks include extreme volatility decay, sector concentration, and macroeconomic sensitivity. The current technical setup suggests cautious entry near support levels may offer better risk-reward positioning.

Returns comparison

Trailing returns across standard periods

About Cytokinetics Inc

Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.

Read more on CYTK

About Direxion Daily Semiconductor Bull 3X Shares

SOXL is a leveraged ETF that seeks daily investment results corresponding to 300% of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bullish (long) position on the semiconductor sector. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.

Read more on SOXL